A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Clinical trial NCT04165317 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04165317
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2024-12-02
- Enrollment
- 1068
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.